Abstract
Before initiating ovulation induction, it is important to evaluate the underlying cause of a patient's anovulation and to make lifestyle modifications or treat underlying medical conditions, as appropriate. Here, ovulation induction agents are discussed with attention to their pharmacology, indications for use, therapy regimens, and efficacy. Adjuvant therapies and appropriate monitoring are also reviewed.
Keywords:
Clomiphene citrate; Gonadotropins; Letrozole; Ovulation induction; Ovulation monitoring.
Copyright © 2015 Elsevier Inc. All rights reserved.
MeSH terms
-
Amenorrhea / etiology
-
Amenorrhea / therapy*
-
Anovulation / drug therapy*
-
Anovulation / etiology
-
Clomiphene / therapeutic use
-
Estrogens / therapeutic use
-
Female
-
Fertility Agents, Female / therapeutic use
-
Gonadotropins / therapeutic use
-
Humans
-
Hypogonadism / complications
-
Hypogonadism / therapy*
-
Infertility, Female / etiology
-
Infertility, Female / therapy*
-
Ovulation Induction / methods*
-
Ovulation Induction / trends
-
Polycystic Ovary Syndrome / complications
-
Polycystic Ovary Syndrome / therapy*
-
Pregnancy
-
Progestins / therapeutic use
Substances
-
Estrogens
-
Fertility Agents, Female
-
Gonadotropins
-
Progestins
-
Clomiphene